Participate in a Clinical Trial

Without the participation of people with MS, it would be impossible to develop new and better therapies and other interventions.

Clinical Trials in MS

The latest clinical research in MS, including trials funded by the Society and trials in progressive MS.

NARCOMS Patient Registry

Register as a willing MS research participant to facilitate multicenter studies. Initiated by the Consortium of MS Centers.

Visit NARCOMS

Posting a Trial

If you would like us to post a study on these pages, please email studies@nmss.org to find out what information you need to submit for review.

Clinical Trials In Your Area

Interested in clinical trials? Simply search by state, type of MS or keyword and see what’s going on in your area.

Clinical Trial: Treatment Strategies to Prevent Disability

A study based at Johns Hopkins University is comparing two treatment strategies in 900 people newly diagnosed, or with onset/diagnosis in the past who have received minimal or no treatment, with the relapsing-remitting form of MS. The study is recruiting at approximately 45 ce...

Get Details
Clinical Trial: Tai Chi and Mindfulness Training

Investigators are recruiting people with all subtypes of MS (participants need to capable of standing and moving unaided for a minimum of 15 minutes at a time) to investigate the impact of mindfulness training on balance and wellbeing in individuals with MS. This is a communit...

Get Details
Clinical Trial: Gut bacteria and MS

The Yale-Griffin Prevention Research Center, the Multiple Sclerosis Treatment Center at Griffin Hospital, and Yale University are teaming up to study whether changing the bacteria in the gut can affect the process that leads to the development of multiple sclerosis (MS). This ...

Get Details
Clinical Trial: Pathological Basis of MRI Signal Changes in Multiple Sclerosis

Multiple sclerosis (MS) is a disease that damages the central nervous system (brain and spinal cord). This leads to increased physical disability over time. The disease is lifelong once it begins. Researchers want to learn more about the stages of multiple sclerosis and follow...

Get Details
Research Study: Seeking first degree relatives of people with MS for study of risk factors

The goal of this study is to learn more about the causes of and risk factors for MS by studying first-degree relatives of people with MS and comparing them to people who are not first-degree relatives of someone with MS. We will use the data collected to develop a risk algorit...

Get Details
Clinical Trial: Computerized Cognitive Training

The purpose of this study is to evaluate two computerized brain training tools, which include light physical activity, to see if they can help improve cognitive functions, such as memory and attention, for people with MS. Participants would complete a set of tests (physical an...

Get Details
Clinical Trial: Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

This study will evaluate the effectiveness and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple sclerosis (PPMS), including participants later in their disease course. This study focuses on upper limit disability progres...

Get Details
Research Study: International MS Microbiome Study

This study aims to understand the role of gut bacteria in MS, and by extension allows us to look at the effects of diet and environment on the gut microbiome and MS disease susceptibility and progression. For this study, we are asking that participants donate blood and stool ...

Get Details
Research Study: cognitive testing for MS

Researchers are currently enrolling participants in a study of cognitive testing for Multiple Sclerosis. This study compares computerized and in-person cognitive testing, to see how well the results match. Participants will complete assessments of sensory, motor, and cognitive...

Get Details
Clinical Trial: Cognitive Processing Speed Changes in Relapsing MS Treated With Ozanimod (RPC-1063)

A study to determine if oral ozanimod can affect cognitive processing speed in people with relapsing MS. All subjects will receive orally administered ozanimod HCl 1 mg. Please note: In response to the recent developments of the COVID-19 pandemic, sites are implementing me...

Get Details

|< < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 > >|

Discover More

Here are a few related topics that may interest you

The National MS Society is Here to Help

Need More Information?

We Are Here

Our MS Navigators help identify solutions and provide access to the resources you are looking for. Call 1-800-344-4867 or contact us online.

Contact an MS Navigator

Newly Diagnosed

If you or somone close to you has recently been diagnosed, access our MS information and resources.

Start Here

Featured Links: >

Participate in a Clinical Trial

Clinical Trials in MS

NARCOMS Patient Registry

Posting a Trial

Share

Clinical Trials In Your Area

Clinical Trial: Treatment Strategies to Prevent Disability

Clinical Trial: Tai Chi and Mindfulness Training

Clinical Trial: Gut bacteria and MS

Clinical Trial: Pathological Basis of MRI Signal Changes in Multiple Sclerosis

Research Study: Seeking first degree relatives of people with MS for study of risk factors

Clinical Trial: Computerized Cognitive Training

Clinical Trial: Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

Research Study: International MS Microbiome Study

Research Study: cognitive testing for MS

Clinical Trial: Cognitive Processing Speed Changes in Relapsing MS Treated With Ozanimod (RPC-1063)

Share

Discover More

The National MS Society is Here to Help

We Are Here